Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Exchange: Hong Kong
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Luye Pharma Group Ltd

+ Add to Watchlist

2186:HK

9.160 HKD 0.080 0.88%

As of 03:01:04 ET on 01/28/2015.

Snapshot for Luye Pharma Group Ltd (2186)

Open: 9.110 Day's Range: 9.030 - 9.250 Volume: 1,825,950
Previous Close: 9.080 52wk Range: 6.510 - 11.540 1-Yr Rtn: -

Stock Chart for 2186

No chart data available.
  • 2186:HK 9.160
  • 1D
  • 1M
  • 1Y
9.080
Interactive 2186 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 2186

Current P/E Ratio (ttm) 11.7162
Estimated P/E(12/2014) 40.3405
Relative P/E vs. HSI 1.1080
Earnings Per Share (CNY) (ttm) 0.6301
Est. EPS (CNY) (12/2014) 0.1830
Est. PEG Ratio -
Market Cap (M HKD) 30,421.04
Shares Outstanding (M) 3,321.07
30 Day Average Volume 8,609,859
Price/Book (mrq) 2.0565
Price/Sale (ttm) 1.4464
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/31/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 2186

No data available

Company Profile & Key Executives for 2186

Luye Pharma Group focuses on the research and development, production, and sales of pharmaceutical drugs for orthopedics, neurology, gastroenterology, and hepatology. The Company also sells active ingredients, R&D results, and patents of new drugs, as well as providing research services on a contractual basis.

Liu Dian BoChairman/FounderLiu Yuan ChongChief Financial Officer
Li You XinExec VP:Research & DevelopmentJiang HuaVP/Head:International Business
More Company Profile & Key Executives for 2186

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil